RDNT Logo

RadNet, Inc. (RDNT) 

NASDAQ
Market Cap
$6.05B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
687 of 774
Rank in Industry
39 of 42

Largest Insider Buys in Sector

RDNT Stock Price History Chart

RDNT Stock Performance

About RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops …

Insider Activity of RadNet, Inc.

Over the last 12 months, insiders at RadNet, Inc. have bought $0 and sold $18.75M worth of RadNet, Inc. stock.

On average, over the past 5 years, insiders at RadNet, Inc. have bought $249,748 and sold $6.64M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,519 shares for transaction amount of $151,271 was made by SWARTZ DAVID L (director) on 2021‑08‑11.

List of Insider Buy and Sell Transactions, RadNet, Inc.

2024-08-21SaleEVP, Mergers and Acquisitions
15,000
0.0202%
$62.78$941,702+7.17%
2024-06-18SaleEVP, Chief Admin Officer
29,800
0.0389%
$59.00$1.76M+12.45%
2024-06-18Saledirector
7,167
0.0095%
$59.75$428,228+12.45%
2024-06-17SaleEVP, Chief Admin Officer
10,200
0.0136%
$60.00$612,000+11.75%
2024-06-17Saledirector
7,167
0.0095%
$59.75$428,228+11.75%
2024-06-14Saledirector
4,000
0.0051%
$57.77$231,080+11.44%
2024-06-12SaleEVP, Chief Science Officer
10,000
0.0138%
$62.34$623,400+5.51%
2024-06-12SalePres & COO-Eastern Operations
40,000
0.0552%
$62.33$2.49M+5.51%
2024-06-12SalePres and COO-West Operations
18,597
0.026%
$63.08$1.17M+5.51%
2024-06-12Saledirector
4,066
0.0056%
$62.42$253,800+5.51%
2024-06-12SaleEVP, Mergers and Acquisitions
10,000
0.0138%
$62.51$625,100+5.51%
2024-06-11SaleEVP, Chief Science Officer
5,000
0.0068%
$61.24$306,200+6.49%
2024-06-11SalePres and COO-West Operations
35,000
0.0476%
$61.40$2.15M+6.49%
2024-06-10Saledirector
20,934
0.0279%
$60.43$1.27M+5.79%
2024-06-10Saledirector
16,000
0.0214%
$60.85$973,600+5.79%
2024-06-10SaleEVP, Chief Financial Officer
25,000
0.0337%
$61.27$1.53M+5.79%
2024-06-10SalePres and COO-West Operations
20,000
0.0269%
$61.13$1.22M+5.79%
2024-06-10Saledirector
1,500
0.002%
$61.03$91,545+5.79%
2024-06-07SaleEVP and Chief Legal Officer
16,400
0.0222%
$61.26$1M+6.16%
2024-06-07Saledirector
3,000
0.0041%
$61.30$183,900+6.16%

Insider Historical Profitability

38.26%
SWARTZ DAVID Ldirector
196476
0.2654%
$81.7214<0.0001%
Levitt Lawrence Ldirector
172657
0.2332%
$81.7226+20.47%
SHERMAN MICHAEL L MDdirector
259083
0.35%
$81.7215+7.31%
Karen B. Kaplan Survivor's Trust
21000
0.0284%
$81.7210+169.3%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$450.51M12.539.26M+4.09%+$17.72M0.01
The Vanguard Group$223.86M6.234.6M+8.13%+$16.83M<0.01
BECK MACK + OLIVER$163.19M4.543.35M+3.83%+$6.02M3.31
State Street$113.57M3.162.33M+5.06%+$5.47M0.01
Jb Capital Partners Lp$97.67M2.722.01M-5.64%-$5.84M3.21
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.